{"id":"F2007B01101","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 11 of 2001)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":67854,"registerId":"commonwealth-F2007B01101-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 11 of 2001)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 11 of 2001\n\nI, BRETT ANTHONY LENNON, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration commences on 1 November 2001.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nBismuth Subcitrate\n\nCerivastatin Sodium\n\nEcothiopate Iodide\n\n“Lofenalac”\n\n“Nutramigen”\n\n“O-Lac”\n\nPilocarpine\n\n“Portagen”\n\n“Pregestimil”\n\nThiabendazole\n\nDated this 3rd day of October 2001.\n\nBRETT ANTHONY LENNON\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Aged Care\n\nDelegate of the Minister for Health and Aged Care","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2460},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The declaration remains precisely targeted on its original purpose of removing specific pharmaceutical benefits from the PBS based on committee advice, with no expansion beyond the administrative intent to delist the ten specified items."},"complexity_factors":["Single operative provision with no conditional logic or exceptions","No defined terms or interpretation section","Minimal cross-referencing (only enabling Act provisions cited)","Straightforward administrative delisting via simple schedule"],"plain_english_summary":"This declaration **removes government subsidies** for ten specific medications and infant formulas from Australia's Pharmaceutical Benefits Scheme (PBS).\n\n**What is being removed:**\n- **Pharmaceuticals**: Bismuth Subcitrate (used for stomach ulcers), Cerivastatin Sodium (a cholesterol-lowering statin), Ecothiopate Iodide and Pilocarpine (both used for glaucoma), and Thiabendazole (an anti-parasitic medication)\n- **Specialised infant formulas**: Lofenalac, Nutramigen, O-Lac, Portagen, and Pregestimil (typically used for infants with metabolic disorders or severe allergies)\n\n**Practical impact:**\nOnce removed from Part VII of the National Health Act (the part that establishes the PBS), these items are no longer subsidised by the Commonwealth. Patients, parents, or carers must pay the full commercial price, or the products may cease to be available in Australia if manufacturers decide not to supply them without PBS listing. The decision follows advice from the Pharmaceutical Benefits Advisory Committee, which assesses the clinical and cost-effectiveness of medicines."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2001/documents"}}